Literature DB >> 12557227

Serrated adenomas and mixed polyposis caused by a splice acceptor deletion in the mouse Smad4 gene.

Peter Hohenstein1, Lia Molenaar, Joyce Elsinga, Hans Morreau, Heleen van der Klift, Ada Struijk, Shantie Jagmohan-Changur, Ron Smits, Henk van Kranen, Gert-Jan B van Ommen, Cees Cornelisse, Peter Devilee, Riccardo Fodde.   

Abstract

Serrated adenomas, hyperplastic polyps, and admixed hyperplastic/adenomatous polyps form a distinct group of colorectal tumors, the molecular genetic basis of which is still poorly understood. We describe a novel mouse model for serrated adenomas and mixed polyposis, here referred to as Sad (serrated adenomas), caused by a spontaneously risen splice site mutation in the murine Smad4 gene. The Sad chromosomal region was identified by genetic linkage and loss of heterozygosity (LOH) analysis. Subsequently, several candidate genes were investigated by expression and mutation analysis. By use of genetic linkage and LOH analysis, we mapped the Sad candidate to mouse chromosome 18, 44-48 cM, syntenic to human chromosome band 18q21. Within this chromosomal interval, the Smad2, Smad4, and Smad7 genes were analyzed for the presence of a disease-causing mutation in affected animals. A single nucleotide (nt) deletion was identified in the intron 5/exon 6 splice acceptor site of the Smad4 gene. The single base deletion results in a frameshift and an early termination codon through activation of a cryptic splice site 4 nt downstream in exon 6. The resulting mRNA is unstable, and the Sad mutation is thus likely to represent a null allele. Identification of a Smad4 mutation in the Sad mouse model provides further support for the involvement of the Smad genes, and thus the TGFB pathway, in the serrated/hyperplastic route to colorectal cancer. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12557227     DOI: 10.1002/gcc.10169

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  12 in total

1.  Smad4 deficiency in T cells leads to the Th17-associated development of premalignant gastroduodenal lesions in mice.

Authors:  Jennifer Nancy Hahn; Vincent George Falck; Frank Robert Jirik
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

Review 2.  Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer.

Authors:  Barbara Jung; Jonas J Staudacher; Daniel Beauchamp
Journal:  Gastroenterology       Date:  2016-10-20       Impact factor: 22.682

Review 3.  Vascular mimicry: Triggers, molecular interactions and in vivo models.

Authors:  Stephen L Wechman; Luni Emdad; Devanand Sarkar; Swadesh K Das; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2020-07-16       Impact factor: 6.242

4.  Histologic variations in juvenile polyp phenotype correlate with genetic defect underlying juvenile polyposis.

Authors:  Willem Arnout van Hattem; Danielle Langeveld; Wendy W J de Leng; Folkert H Morsink; Paul J van Diest; Christine A Iacobuzio-Donahue; Francis M Giardiello; G Johan A Offerhaus; Lodewijk A A Brosens
Journal:  Am J Surg Pathol       Date:  2011-04       Impact factor: 6.394

Review 5.  Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.

Authors:  Parry Guilford; Bostjan Humar; Vanessa Blair
Journal:  Gastric Cancer       Date:  2010-04-07       Impact factor: 7.370

6.  Enhancement of TGF-β signaling responses by the E3 ubiquitin ligase Arkadia provides tumor suppression in colorectal cancer.

Authors:  Vikas Sharma; Anna G Antonacopoulou; Shinya Tanaka; Alexios A Panoutsopoulos; Vasiliki Bravou; Haralabos P Kalofonos; Vasso Episkopou
Journal:  Cancer Res       Date:  2011-10-15       Impact factor: 12.701

7.  Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development.

Authors:  Qinghua Zeng; Sharbani Phukan; Yanfei Xu; Maureen Sadim; Diana S Rosman; Michael Pennison; Jie Liao; Guang-Yu Yang; Chiang-Ching Huang; Laura Valle; Antonio Di Cristofano; Albert de la Chapelle; Boris Pasche
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

8.  Increased cyclooxygenase-2 expression in juvenile polyposis syndrome.

Authors:  W Arnout van Hattem; Lodewijk A A Brosens; Susan Y Marks; Anya N A Milne; Susanne van Eeden; Christine A Iacobuzio-Donahue; Ari Ristimäki; Francis M Giardiello; G Johan A Offerhaus
Journal:  Clin Gastroenterol Hepatol       Date:  2008-08-05       Impact factor: 11.382

Review 9.  Cancer stem cells: the 'heartbeat' of gastric cancer.

Authors:  Guihua Xu; Jie Shen; Xiaohui Ou Yang; Masakiyo Sasahara; Xiulan Su
Journal:  J Gastroenterol       Date:  2012-11-27       Impact factor: 7.527

10.  A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis.

Authors:  Claudia Gaspar; Patrick Franken; Lia Molenaar; Cor Breukel; Martin van der Valk; Ron Smits; Riccardo Fodde
Journal:  PLoS Genet       Date:  2009-07-03       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.